Backing Down On Forward Funding? HHS Now Says It Won’t Make Multiple Year Awards Until September
In Brief: AACR Lectures Listed; Winn Heads Community Oncology At MDA; Henderson ACS Grant Renewed
FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin
B.J. Kennedy Receives ACCC Award, Says More Medical Oncologists Are Still Needed
Trombold Tells How Scripps Raises Money for Cancer Center, Gets Independent From “Whiny Administrator”
McKenna Sees Budget Cuts as Threat to Year 2000 Goals Urges Stepped Up Efforts Against Tobacco Industry
Trending Stories
- Spending bill passed by the House gives NIH $415M raise, NCI gets $128M
Legislation caps proportion of NIH grants to receive multiyear funding; indirect costs remain untouched - With five-year cancer survival at an all-time high, does this mean people are living longer?
- Blood Cancer United: A new name at the right moment
- An oncologist navigates terminal sarcoma, insurmountable debt, and “a legacy of grief”
How colleagues and Fargo, ND, neighbors came together to help the Erickson-Abou Zahrs - In The Headlines: Is early detection always good? Inside NCI’s MCD feasibility trial.
- Premarin’s 84-year hold on the market ends as FDA approves a generic version
Trade secret protections helped the hormone drug resist generic entry and outlast safety controversies—including link to cancer
